reference/2238002

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2238002

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	34
issn	1572-0241 0002-9270
issueIdentifier	1
pageRange	ajg20016-34
publicationName	The American Journal of Gastroenterology
startingPage	ajg20016
bibliographicCitation	Johnson DA, Benjamin SB, Vakil NB, Goldstein JL, Lamet M, Whipple J, D'Amico D, Hamelin B. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety. The American Journal of Gastroenterology. 2001 Jan 01;96(1):ajg20016. doi: 10.1111/j.1572-0241.2001.03443.x.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ffeaf0f1a6a5e3c9b1a8c0ec3f0ae678 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f52e7323aa5786d390465f18f84be82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8fea9f064ed71d2813f1e378036ab34 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9d74095fb52b20f306083e9e46da444 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a95cfec6e3d0605899b768a8c9c7481f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_380fca6de2639c07d0e9af47bcbb39d8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb03b2e962693057e1d2d6bba2a0db37 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df304709c5d142c30d141508a0229f16
date	2001-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/s0002-9270%2800%2902236-x https://pubmed.ncbi.nlm.nih.gov/11197282 https://doi.org/10.1111/j.1572-0241.2001.03443.x
isPartOf	https://portal.issn.org/resource/ISSN/0002-9270 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/426 https://portal.issn.org/resource/ISSN/1572-0241
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety
discusses	http://id.nlm.nih.gov/mesh/M0427109 http://id.nlm.nih.gov/mesh/M0007520 http://id.nlm.nih.gov/mesh/M0015293
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103 http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7655 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_253b653277908a873c242da1c5cfa8a7 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0f3c36396b4022bf2219ee625452a634 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9568614 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7932 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7810 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9579578

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129288902 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129288905

Total number of triples: 44.